Maintenance erlotinib improves clinical outcomes of unresectable advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

The aim of this study was to evaluate the efficacy and safety of erlotinib as maintenance therapy in patients with unresectable non-small cell lung cancer (NSCLC) by evidence-based methodology. Six eligible studies including 4,372 patients were analyzed. Erlotinib was administered to 2,191 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, JIAN, ZHANG, WEIQING, HUANG, SHAOHONG, LI, HUI, LI, YUN, CHEN, HUIGUO, WU, WEIBING, ZHOU, WEI, WANG, CUIPING, LIAO, HONGYING, GU, LIJIA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493745/
https://www.ncbi.nlm.nih.gov/pubmed/23226738
http://dx.doi.org/10.3892/etm.2012.690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493745/
https://www.ncbi.nlm.nih.gov/pubmed/23226738
http://dx.doi.org/10.3892/etm.2012.690

Ejemplares similares